Mapping of human monoclonal antibody responses to XBB.1.5 COVID-19 monovalent vaccines: a B cell analysis
Lancet Microbe. 2025 Aug;6(8):101103. doi: 10.1016/j.lanmic.2025.101103. Epub 2025 May 30.
PMID:
Secondary laryngeal manifestation of cavitary pulmonary tuberculosis
Infection. 2025 Jun 2. doi: 10.1007/s15010-025-02570-4. Online ahead of print.
PMID:
Corrigendum to “Underlying health biases in previously-infected SARS-CoV-2 vaccination recipients: A cohort study” [J Infect 90 (2025) 106497]
J Infect. 2025 Jul;91(1):106522. doi: 10.1016/j.jinf.2025.106522. Epub 2025 May 28.
PMID:
Puumala orthohantavirus: prevalence, biology, disease, animal models and recent advances in therapeutics development and structural biology
Front Immunol. 2025 May 8;16:1575112. doi: 10.3389/fimmu.2025.1575112. eCollection 2025.
PMID:
Humoral SARS-CoV-2 vaccine responses are durable in solid organ transplant recipients with and without HIV
medRxiv [Preprint]. 2025 May 8:2025.05.07.25327192. doi: 10.1101/2025.05.07.25327192.
PMID:
Nosocomial lower respiratory tract infections in patients with immunosuppression: a cohort study
Ann Intensive Care. 2025 May 6;15(1):61. doi: 10.1186/s13613-025-01462-y.
PMID:
Underlying health biases in previously-infected SARS-CoV-2 vaccination recipients: A cohort study
J Infect. 2025 Jun;90(6):106497. doi: 10.1016/j.jinf.2025.106497. Epub 2025 Apr 30.
PMID:
Vaccination with ancestral SARS-CoV-2 spike adjuvanted with TLR agonists provides cross-protection against XBB.1
Npj Viruses. 2024 Aug 6;2(1):28. doi: 10.1038/s44298-024-00038-0.
PMID:
Prevalence of Chronic Pulmonary Aspergillosis in Patients With Mycobacterial and Non-Mycobacterial Tuberculosis Infection of the Lung: A Systematic Review and Meta-Analysis
Mycoses. 2025 Apr;68(4):e70060. doi: 10.1111/myc.70060.
PMID:
Diabetes, glycaemic traits and cardiovascular disease in females and males: Observational and Mendelian randomisation analyses in the UK Biobank
Diabetes Obes Metab. 2025 Jul;27(7):3789-3799. doi: 10.1111/dom.16406. Epub 2025 Apr 21.
PMID: